MLS(002745)
Search documents
木林森:公司未来将同时布局显示与光互联
Zheng Quan Ri Bao Zhi Sheng· 2025-09-29 09:39
Core Viewpoint - Company Mulinson highlights the significant potential of Micro-LED technology in both display and optical interconnection fields, driven by the explosive growth of AI computing power and the increasing demand for high-speed optical interconnection in data centers [1] Group 1: Micro-LED Technology Potential - Micro-LED is identified as a potential core light source that can significantly enhance the performance of optical modules [1] - The relationship between display and optical interconnection is described as complementary rather than opposing, sharing core technologies such as packaging and driving [1] Group 2: Strategic Positioning - The expansion into optical interconnection will not divert resources but will instead broaden the application boundaries of Micro-LED, extending from consumer electronics displays to AI infrastructure [1] - The company's future strategy involves simultaneous development in both display and optical interconnection, aligning with technological evolution and market demand to maximize the commercial value of Micro-LED [1]
木林森与京东科技达成战略合作
Zheng Quan Shi Bao Wang· 2025-09-26 12:25
Core Viewpoint - Mulinson (002745) has signed a strategic cooperation framework agreement with JD Technology, establishing a comprehensive strategic partnership [1] Group 1: Global Layout and Smart Upgrade - The cooperation will focus on optimizing Mulinson's global supply chain system through JD Technology's digital capabilities [1] - A key initiative includes the establishment of a demonstration base for unmanned warehouses in Europe to enhance logistics efficiency and reduce operational costs [1] Group 2: Technical Synergy and Industry Complementation - Mulinson will leverage its sales network covering over 150 countries in conjunction with JD Technology's strengths in AI and cloud computing to jointly develop smart manufacturing solutions [1] - The partnership plans to launch customized enterprise security solutions to optimize human resource structures and enhance talent attraction [1]
木林森(002745.SZ):在光互联这一交叉领域,公司不排除未来与光通信领域的领先企业展开合作
Ge Long Hui· 2025-09-26 07:24
格隆汇9月26日丨木林森(002745.SZ)在投资者互动平台表示,公司对前瞻性技术布局始终持积极态度, Micro-LED与LED产业的强关联性使其天然具备成为行业头部的潜力。在光互联这一交叉领域,公司不 排除未来与光通信领域的领先企业展开合作,通过优势互补——例如公司提供高精度封装能力,合作伙 伴贡献光模块经验——共同推动技术落地。这种开放合作模式既能加速产业化进程,又能确保公司在新 兴赛道中占据关键位置,为长期增长注入新动能。 ...
光学光电子板块9月24日涨0.31%,盛洋科技领涨,主力资金净流入8810.2万元
Zheng Xing Xing Ye Ri Bao· 2025-09-24 08:39
Core Insights - The optical and optoelectronic sector experienced a slight increase of 0.31% on September 24, with Shengyang Technology leading the gains [1] - The Shanghai Composite Index closed at 3853.64, up 0.83%, while the Shenzhen Component Index closed at 13356.14, up 1.8% [1] Stock Performance - Shengyang Technology (603703) closed at 11.31, with a rise of 10.02% and a trading volume of 323,600 shares, amounting to a transaction value of 355 million [1] - Baoming Technology (002992) closed at 59.06, up 9.35%, with a trading volume of 71,700 shares and a transaction value of 412 million [1] - Meidike (688079) closed at 13.69, increasing by 8.31%, with a trading volume of 154,500 shares and a transaction value of 207 million [1] - Hehui Optoelectronics (688538) closed at 2.92, up 8.15%, with a trading volume of 3,934,600 shares and a transaction value of 1.148 billion [1] - Tianshan Electronics (301379) closed at 31.98, rising by 6.81%, with a trading volume of 334,800 shares and a transaction value of 1.034 billion [1] - Qianzhao Optoelectronics (300102) closed at 12.80, up 5.09%, with a trading volume of 260,500 shares and a transaction value of 325 million [1] - Huichuangda (300909) closed at 34.44, increasing by 5.00%, with a trading volume of 86,300 shares and a transaction value of 293 million [1] - Xiangteng New Materials (001373) closed at 30.97, up 4.91%, with a trading volume of 21,500 shares and a transaction value of 65.524 million [1] - ST Hengjiu (002808) closed at 4.70, rising by 4.91%, with a trading volume of 65,500 shares and a transaction value of 30.521 million [1] - Sanan Optoelectronics (600703) closed at 15.64, up 4.83%, with a trading volume of 1,997,800 shares and a transaction value of 3.081 billion [1] Fund Flow - The optical and optoelectronic sector saw a net inflow of 88.102 million from main funds, while retail funds experienced a net inflow of 77.9 million [2] - However, there was a net outflow of 867 million from speculative funds [2]
调研速递|木林森接受广东辖区投资者网上集体接待日活动超百家机构调研,聚焦市值、新质生产力等要点
Xin Lang Cai Jing· 2025-09-19 12:10
Group 1 - The company held an investor relations activity on September 19, 2025, focusing on its market value and strategic plans [1] - Investors raised concerns about the company's stock price being lower than loss-making stocks and those at risk of delisting, to which the company responded that market fluctuations are influenced by macroeconomic conditions and industry cycles [1] - The company aims to enhance its profitability and competitiveness while focusing on its core business to improve intrinsic value and market capitalization [1] Group 2 - The company plans to break away from traditional manufacturing labels by developing a closed-loop production chain and expanding into emerging fields such as smart and health lighting [1] - The company reported sales of over 15,000 units of its oxygen sleep instrument on Douyin, indicating a robust online and offline sales network [1] - The company has established a comprehensive sales system that includes online content e-commerce and collaborations with influencers, as well as a national network of flagship operation centers in key cities [1] Group 3 - The company believes that the future of the industry will focus on intelligence and sustainability, with smart lighting penetrating various scenarios and green low-carbon lighting becoming mainstream [1] - The company plans to increase R&D investment in smart and low-carbon lighting, solidify its position in the high-end markets of Europe and America, and explore emerging markets [1] - The acquisition of 51% of New航科技 and 18.77% of 普瑞光电 is expected to facilitate entry into new fields and expand the lighting sector [1] Group 4 - The company reported a significant decline in revenue and net profit in the 2025 mid-year report, with revenue down by 200 million and net profit down by 11 million [1] - The increase in sales and R&D expenses, amounting to 100 million and 48 million respectively, is attributed to strategic investments in overseas sales channels and new product development [1] - The company anticipates that the effects of these investments will gradually become evident in the second half of the year [1]
木林森(002745) - 002745木林森投资者关系管理信息20250919
2025-09-19 10:58
Group 1: Company Performance and Market Position - The company's stock price and market value are currently lower than expected, especially compared to loss-making stocks, raising concerns among investors about its valuation [2] - The company aims to enhance overall profitability and competitiveness to improve intrinsic value and market capitalization [2][3] - In the first half of 2025, the company reported a significant decline in revenue and net profit, with a decrease of 200 million and 110 million respectively [4] Group 2: Strategic Initiatives and Future Plans - The company plans to break traditional manufacturing boundaries by increasing R&D investment and focusing on core technologies [3] - Future development will center on smart and green technologies, aligning with global carbon neutrality goals [3] - The company is expanding its sales network in the health sector through a multi-channel approach, including online, offline, and overseas strategies [3] Group 3: Financial Management and Investment - Increased sales and R&D expenses were noted, with sales expenses rising by 100 million and R&D expenses by 48 million, aimed at long-term market share growth [4] - The company has made strategic investments in new markets and customer development to support revenue growth [4] - Acquisitions of 51% of Xinhang Technology and 18.77% of Puri Optoelectronics are expected to enhance the company's presence in new fields and expand its lighting sector [5]
木林森跌2.02%,成交额4.85亿元,主力资金净流出4496.33万元
Xin Lang Cai Jing· 2025-09-19 03:28
Core Viewpoint - Mulinson's stock has experienced fluctuations, with a recent decline of 2.02%, while the company has shown a year-to-date increase of 11.65% in stock price [1][2]. Group 1: Stock Performance - As of September 19, Mulinson's stock price was 9.68 CNY per share, with a market capitalization of 14.367 billion CNY [1]. - The stock has seen a trading volume of 4.85 billion CNY and a turnover rate of 4.62% [1]. - Year-to-date, the stock price has increased by 11.65%, with a 7.92% rise over the last five trading days, 3.75% over the last twenty days, and 24.26% over the last sixty days [1]. Group 2: Financial Performance - For the first half of 2025, Mulinson reported a revenue of 7.919 billion CNY, a year-on-year decrease of 3.21%, and a net profit attributable to shareholders of 154 million CNY, down 41.45% year-on-year [2]. - The company has distributed a total of 2.466 billion CNY in dividends since its A-share listing, with 1.259 billion CNY distributed in the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, Mulinson had 52,500 shareholders, an increase of 6.97% from the previous period, with an average of 20,263 circulating shares per shareholder, a decrease of 6.51% [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 69.7175 million shares, an increase of 14.7531 million shares from the previous period [3].
木林森股价涨5.95%,南方基金旗下1只基金位居十大流通股东,持有960.03万股浮盈赚取528.02万元
Xin Lang Cai Jing· 2025-09-18 02:07
截至发稿,崔蕾累计任职时间6年317天,现任基金资产总规模949.76亿元,任职期间最佳基金回报 142.69%, 任职期间最差基金回报-15.93%。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 责任编辑:小浪快报 数据显示,南方基金旗下1只基金位居木林森十大流通股东。南方中证1000ETF(512100)二季度增持 182.57万股,持有股数960.03万股,占流通股的比例为0.9%。根据测算,今日浮盈赚取约528.02万元。 南方中证1000ETF(512100)成立日期2016年9月29日,最新规模649.53亿。今年以来收益28.17%,同 类排名1822/4222;近一年收益72.87%,同类排名1263/3804;成立以来收益13.43%。 南方中证1000ETF(512100)基金经理为崔蕾。 9月18日,木林森涨5.95%,截至发稿,报9.80元/股,成交2.51亿元,换手率2.47%,总市值145.45亿 元。 资料显示,木林森股份有限公司位于广东 ...
木林森涨2.11%,成交额1.40亿元,主力资金净流入137.56万元
Xin Lang Cai Jing· 2025-09-11 06:43
Core Viewpoint - Mulinson's stock has shown a slight increase in price and trading activity, with a notable rise in market capitalization, despite a decline in revenue and net profit for the first half of 2025 [1][2]. Group 1: Stock Performance - On September 11, Mulinson's stock price increased by 2.11%, reaching 8.71 CNY per share, with a trading volume of 1.40 billion CNY and a turnover rate of 1.53%, resulting in a total market capitalization of 129.27 billion CNY [1]. - Year-to-date, Mulinson's stock price has risen by 0.46%, with a 5-day increase of 2.83%, a 20-day increase of 3.94%, and a 60-day increase of 15.82% [1]. Group 2: Financial Performance - For the first half of 2025, Mulinson reported a revenue of 79.19 billion CNY, a year-on-year decrease of 3.21%, and a net profit attributable to shareholders of 1.54 billion CNY, down 41.45% compared to the previous year [2]. - Since its A-share listing, Mulinson has distributed a total of 24.66 billion CNY in dividends, with 12.59 billion CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of June 30, 2025, Mulinson had 52,500 shareholders, an increase of 6.97% from the previous period, with an average of 20,263 circulating shares per shareholder, a decrease of 6.51% [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 69.72 million shares, an increase of 14.75 million shares from the previous period [3].
木林森:8月27日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-28 01:02
Group 1 - The company Mulinson held its sixth second board meeting on August 27, 2025, to review the proposal for the 2025 semi-annual report and summary [1] - The meeting took place in the company's first-floor conference room [1] Group 2 - The news highlights a significant advancement in medical science with the world's first successful transplantation of gene-edited pig lungs into humans [1] - The article discusses the perspectives of key participants regarding the timeline for clinical application of this breakthrough [1]